Skip to main content

Inactivation of PI3K-C2α deregulates cell death pathways and sensitizes to endotoxic shock.

Proceedings of the National Academy of Sciences of the United States of America2025-07-17PubMed
Total: 82.5Rigor: 9Innovation: 9Journal: 8Clinical: 5

Summary

Genetic inactivation of PI3K-C2α in adult mice is physiologically tolerated but markedly increases susceptibility to LPS-induced endotoxic shock. Endothelial-specific deletion recapitulates the phenotype, and combined caspase-8/RIPK3 deficiency rescues it, implicating extrinsic cell death pathways.

Key Findings

  • Systemic PI3K-C2α inactivation in adult mice is well tolerated under baseline conditions.
  • PI3K-C2α inactivation markedly sensitizes mice to LPS-induced endotoxic shock.
  • Endothelial-specific PI3K-C2α deletion reproduces LPS sensitization.
  • Caspase-8 and RIPK3 double deficiency rescues LPS sensitization, implicating extrinsic cell death pathways.

Clinical Implications

While not immediately practice-changing, findings caution against indiscriminate systemic PI3K-C2α inhibition in patients at risk of infection and highlight extrinsic apoptosis/necroptosis as potential therapeutic nodes in septic shock.

Why It Matters

This mechanistic discovery identifies PI3K-C2α as a gatekeeper of extrinsic cell death in endotoxemia, with implications for the safety of emerging PI3K-C2α inhibitors and for therapeutic modulation of cell death in sepsis.

Limitations

  • Findings are from murine models (endotoxic shock), which may not fully capture human sepsis complexity
  • Lack of direct testing in infectious sepsis models and absence of human interventional data

Future Directions

Evaluate PI3K-C2α modulation in infectious sepsis models, define endothelial signaling downstream of PI3K-C2α, and assess safety of PI3K-C2α inhibitors in infection-prone settings.

Study Information

Study Type
Cohort
Research Domain
Pathophysiology
Evidence Level
V - Preclinical mechanistic study in murine models with genetic perturbations
Study Design
OTHER